Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results-Reference-Cited by-同舟云学术

Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results

Published:2005-12 Issue:6 Volume:15 Page:523-529
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:Melanoma Research

Author:

Valencak Julia,Heere-Ress Elisabeth,Traub-Weidinger Tatjana,Raderer Markus,Schneeberger Achim,Thalhammer Theresia,Aust Sylvia,Hamilton Gerhard,Virgolini Irene,Pehamberger Hubert

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference35 articles.

1. The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

2. Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results

3. Radiolabeled peptides in the diagnosis and therapy of oncological diseases

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Octreotide attenuates intestinal barrier damage by maintaining basal autophagy in Caco2 cells;Molecular Medicine Reports;2024-04-03

2. A Radiolabeled Self-assembled Nanoparticle Probe for Diagnosis of Lung-Metastatic Melanoma;Biological and Pharmaceutical Bulletin;2021-03-01

3. PET and SPECT imaging of melanoma: the state of the art;European Journal of Nuclear Medicine and Molecular Imaging;2017-10-30

4. Metastatic Melanoma to the Thyroid Gland Expressing Somatostatin Receptors—Imaging With 68Ga-DOTANOC PET/CT;Clinical Nuclear Medicine;2015-02

5. Gallium-68: Chemistry and Radiolabeled Peptides Exploring Different Oncogenic Pathways;Cancer Biotherapy and Radiopharmaceuticals;2013-03